VC Deals Analysis: Best Q1 Yet With Unrelenting Bull Run
Executive Summary
The pace of medtech venture financing activity did not slacken in March, as the month welcomed yet another batch of big financing rounds, making it the most prolific first-quarter in the last three years for fundraisings of $100m-and-over.